Theralase® Technologies Inc.
About Theralase® Technologies Inc.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Non-Brokered Private Placement T: - FT: Non-Brokered Private Placement |
A: 1334650 MR: - FA: 1,334,650 CAD FAN: 1334650 |
D: 2025-12-23 FD: 2025-12-23 |
- |
| 2 |
RT: Non-brokered private placement T: - FT: Non-brokered private placement |
A: 2000000 MR: - FA: up to $CAN 2,000,000 FAN: 2000000 |
D: 2025-12-12 FD: 2025-12-12 |
- |
| 3 |
RT: Warrant Extension T: - FT: Warrant Extension |
A: 644000 MR: - FA: 644,000 CAD (potential from exercising 1,840,000 warrants at $0.35 each) FAN: 644000 |
D: 2025-08-29 FD: 2025-08-29 |
- |
| 4 |
RT: Non-Brokered Private Placement T: - FT: Non-Brokered Private Placement |
A: 672627 MR: - FA: approximately $CAN 672,627 FAN: 672627 |
D: 2025-07-28 FD: 2025-07-28 |
- |
| 5 |
RT: Non-brokered Private Placement T: - FT: Non-brokered Private Placement |
A: 571000 MR: - FA: approximately $CAN 571,000 FAN: 571000 |
D: 2025-06-17 FD: 2025-06-17 |
- |
| 6 |
RT: Non-brokered Private Placement T: - FT: Non-brokered Private Placement |
A: 419124 MR: - FA: $CAN 419,124 FAN: 419124 |
D: 2025-04-14 FD: 2025-04-14 |
- |
| 7 |
RT: Non-brokered Private Placement T: - FT: Non-brokered Private Placement |
A: 310200 MR: - FA: approximately $CAN 310,200 FAN: 310200 |
D: 2025-03-11 FD: 2025-03-11 |
- |
| 8 |
RT: Non-brokered Private Placement T: - FT: Non-brokered Private Placement |
A: 666400 MR: - FA: approximately $CAN 666,400 FAN: 666400 |
D: 2024-11-15 FD: 2024-11-15 |
- |
| 9 |
RT: Warrant Extension T: - FT: Warrant Extension |
A: 350000 MR: - FA: 350000 FAN: 350000 |
D: 2024-11-12 FD: 2024-11-12 |
- |
| 10 |
RT: Non-Brokered Private Placement T: - FT: Non-Brokered Private Placement |
A: 544000 MR: - FA: $CAN 544,000 FAN: 544000 |
D: 2024-09-24 FD: 2024-09-24 |
- |
| 11 |
RT: Warrant Extension (from previous private placement) T: - FT: Warrant Extension (from previous private placement) |
A: 3500000 MR: - FA: 10,000,000 warrants at $0.35 per share FAN: 3500000 |
D: 2024-09-19 FD: 2024-09-19 |
- |
| 12 |
RT: Non-Brokered Private Placement T: - FT: Non-Brokered Private Placement |
A: 775000 MR: - FA: 775,000 FAN: 775000 |
D: 2024-07-08 FD: 2024-07-08 |
- |
| 13 |
RT: Non-Brokered Private Placement T: - FT: Non-Brokered Private Placement |
A: 1200000 MR: - FA: CAN 1,200,000 FAN: 1200000 |
D: 2024-02-05 FD: 2024-02-05 |
- |
| 14 |
RT: Non-brokered Private Placement T: - FT: Non-brokered Private Placement |
A: 1170000 MR: - FA: 1,170,000 FAN: 1170000 |
D: 2023-11-29 FD: 2023-11-29 |
- |
| 15 |
RT: Non-brokered Private Placement T: - FT: Non-brokered Private Placement |
A: 1500000 MR: - FA: up to $CAN 1.5 M FAN: 1500000 |
D: 2023-11-17 FD: 2023-11-17 |
- |
| 16 |
RT: Brokered Offering (LIFE Financing) T: - FT: Brokered Offering (LIFE Financing) |
A: 5300000 MR: - FA: Up to C$5,300,000 FAN: 5300000 |
D: 2023-10-23 FD: 2023-10-23 |
1 investors |
| 17 |
RT: Non-brokered Private Placement T: - FT: Non-brokered Private Placement |
A: 1200000 MR: - FA: approximately $1,200,000 FAN: 1200000 |
D: 2023-06-30 FD: 2023-06-30 |
- |
Growth Metrics
Team & Leadership
Roger Dumoulin-White
President and Chief Executive Officer
Kristina Hachey
Chief Financial Officer, Director
Arkady Mandel
Chief Scientific Officer
Guy Anderson
Director
Matthew Perraton
Chairman of the Board, Director
Randy Bruder
Director
Recent News
Theralase® Technologies Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- theralase.com
- Industries
- Healthcare / Medical Technology
- Company Size
- ~420 employees (est.)
- Locations
-
TORONTO, ON
Toronto, ON
Toronto, Ontario, Canada +1 more
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro